XML 25 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
Debt (Tables)
9 Months Ended
Sep. 30, 2013
Debt Instrument [Line Items]  
Schedule of principal amounts, unamortized discount and net carrying amounts
The following table sets forth information related to the 3.00% convertible senior notes which is included our Condensed Consolidated Balance Sheets:
(In thousands)
Embedded conversion option
 
Convertible Notes
 
Discount
 
Total
Balance at December 31, 2012
$

 
$

 
$

 
$

Issuance of 3.00% convertible notes
59,204

 
175,000

 
(59,204
)
 
175,000

Amortization of debt discount

 

 
4,866

 
4,866

Debt discount write-off associated with conversion
    of debt

 

 
5,368

 
5,368

Change in fair value of embedded derivative
41,818

 

 

 
41,818

Conversion
(1,199
)
 
(16,936
)
 

 
(18,135
)
Balance at September 30, 2013
$
99,823

 
$
158,064

 
$
(48,970
)
 
$
208,917

Summary of lines of credit
The following table summarizes the amounts outstanding under the lines of credit:
(Dollars in thousands)
 
 
 
 
 
 Balance Outstanding
Lender
 
Interest rate on
borrowings
 
Credit line
capacity
 
September 30,
2013
 
December 31,
2012
Itau Bank
 
8.04
%
 
$
3,000

 
$
2,207

 
$
2,738

Bank of Chile
 
7.80
%
 
3,000

 
1,967

 
2,292

BICE Bank
 
5.50
%
 
1,500

 
867

 
2,451

Corp Banca
 
5.50
%
 

 
28

 
1,248

BBVA Bank
 
8.29
%
 
2,500

 
1,230

 
2,823

Penta Bank
 
9.48
%
 
800

 
992

 
833

Security Bank
 
7.56
%
 
1,500

 
1,063

 

BCI
 
5.50
%
 
1,000

 
1,216

 

Estado Bank
 
6.88
%
 
2,000

 
1,732

 
1,963

Sabadell Bank
 
7.60
%
 
203

 

 
3

Bilbao Vizcaya Bank
 
4.90
%
 
406

 
91

 
377

Banco Popular
 
8.25
%
 
406

 

 
260

Santander Bank
 
6.00
%
 
203

 

 

Banesto
 
5.80
%
 
203

 
4

 
163

Banca March
 
6.25
%
 
270

 

 
44

Total
 
 
 
$
16,991

 
$
11,397

 
$
15,195

Farmadiet Acquisition [Member]
 
Debt Instrument [Line Items]  
Schedule of principal amounts, unamortized discount and net carrying amounts
At September 30, 2013 and December 31, 2012, we had mortgage notes and other debt payables related to Farmadiet as follows:
(In thousands)
September 30,
2013
 
December 31,
2012
Current portion of lines of credit and notes payable
$
1,796

 
$
2,331

Other long-term liabilities
3,350

 
3,916

Total mortgage notes and other debt payables
$
5,146

 
$
6,247

Notes [Member]
 
Debt Instrument [Line Items]  
Inputs to lattice model used to value the embedded derivative
The following table sets forth the inputs to the lattice model used to value the embedded derivative:
 
September 30, 2013
 
Issuance Date
Stock price
$
8.81

 
$
6.20

Conversion Rate
141.4827

 
141.4827

Conversion Price
$
7.07

 
$
7.07

Maturity date
February 1, 2033

 
February 1, 2033

Risk-free interest rate
1.50
%
 
1.12
%
Estimated stock volatility
40
%
 
40
%
Estimated credit spread
948 basis points

 
944 basis points

Fair value of notes with and without the embedded derivatives and fair value of embedded derivatives
The following table sets forth the fair value of the Notes with and without the embedded derivatives, and the fair value of the embedded derivatives as of the issuance date and September 30, 2013. At September 30, 2013 and at issuance date the principal amount of the Notes was $158.1 million and $175.0 million, respectively:
(In thousands)
September 30, 2013
 
Issuance Date
Fair value of Notes:
 
 
 
With the embedded derivatives
$
210,105

 
$
175,000

Without the embedded derivatives
$
110,282

 
$
115,796

Estimated fair value of the embedded derivatives
$
99,823

 
$
59,204